Article 2U.K.
1.When allowing the placing on the market of biocidal products containing temephos in accordance with Article 1, France shall ensure that the following conditions are complied with:
(a)continued use is only possible under the conditions that biocidal products containing temephos are approved for the intended essential use;
(b)the continued use is only accepted so far as it has no unacceptable effect on human or animal health or on the environment;
(c)all appropriate risk reduction measures are imposed when granting approval;
(d)such biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the restricted use conditions;
(e)where appropriate, alternatives for such uses are being sought by the holders of the approvals or by France.
2.France shall inform the Commission annually on the application of paragraph 1 and in particular on the actions taken pursuant to point (e) of that paragraph.